Showing results (2991-3000 of 9,187) with videos related to
Sort By:
Pageof 919
Cancer Medicine|December 18, 2021
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myelomaDarren Pan, Jonathan L Kaufman, Myo Htut, et al.Cancer Medicine|November 29, 2021
Pan-cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitorsJunjie Jiang, Yongfeng Ding, Yanyan Chen, et al.Cancer Medicine|November 11, 2021
Protective role of cytoplasmic p21Cip1/Waf1 in apoptosis of CDK4/6 inhibitor-induced senescence in breast cancer cellsIrna D Kartika, Hitoshi Kotani, Yuichi Iida, et al.Cancer Medicine|November 11, 2021
Comparison of allogeneic hematopoietic stem cell transplantation and TKI combined with chemotherapy for adult philadelphia chromosome positive acute lymphoblastic leukemia: a systematic review and meta-analysisQiang Zeng, Bing Xiang, Zhigang LiuCancer Medicine|November 6, 2021
Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancerYuan-Zhong Yang, Wan-Ming Hu, Liang-Ping Xia, et al.Cancer Medicine|November 8, 2021
Clinico-cytopathologic analysis of 574 Pericardial Effusion Specimens: Application of the international system for reporting serous fluid cytopathology (ISRSFC) and long-term clinical follow-upMin Jeong Song, Uiree Jo, Ji-Seon Jeong, et al.Cancer Medicine|December 1, 2021
Cancer registry study of malignant hepatic vascular tumors: hepatic angiosarcomas and hepatic epithelioid hemangioendotheliomasConstanza Martínez, Jonathan K Lai, Daryl Ramai, et al.Cancer Medicine|December 4, 2021
ENPEP as a potential predictor of immune checkpoint inhibitor efficacyAoyun Wang, Han Chu, Zheng Jin, et al.Cancer Medicine|December 4, 2021
Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population-based cohort studyZhen Yang, Guangjun ShiCancer Medicine|March 4, 2021
An immune-related seven-lncRNA signature for head and neck squamous cell carcinomaYue Chen, Tian-Qi Luo, Si-Si Xu, et al.Pageof 919